Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves

Bronchoscopic lung volume reduction treatment with Zephyr one-way valves is an effective guideline-based treatment option for patients with severe emphysema and hyperinflation. However, in some cases the treatment response is less than anticipated or there might be a loss of initial treatment effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Koster, David (VerfasserIn) , Shah, Pallav L. (VerfasserIn) , Valipour, Arschang (VerfasserIn) , Criner, Gerard J. (VerfasserIn) , Herth, Felix (VerfasserIn) , Sue, Richard (VerfasserIn) , Hogarth, Douglas K. (VerfasserIn) , Martin, Ralitza T. (VerfasserIn) , Mahajan, Amit K. (VerfasserIn) , Alalawi, Raed (VerfasserIn) , Kopas, Lisa (VerfasserIn) , Cohen, Avi (VerfasserIn) , Wood, Douglas E. (VerfasserIn) , Kurman, Jonathan (VerfasserIn) , Shargill, Narinder S. (VerfasserIn) , Dransfield, Mark (VerfasserIn) , Slebos, Dirk-Jan (VerfasserIn) , Perch, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 2024
In: Respiratory medicine
Year: 2024, Jahrgang: 227
ISSN:1532-3064
DOI:10.1016/j.rmed.2024.107639
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.rmed.2024.107639
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0954611124001136
Volltext
Verfasserangaben:T. David Koster, Pallav L. Shah, Arschang Valipour, Gerard J. Criner, Felix J. F. Herth, Richard Sue, Douglas K. Hogarth, Ralitza T. Martin, Amit K. Mahajan, Raed Alalawi, Lisa Kopas, Avi Cohen, Douglas E. Wood, Jonathan Kurman, Narinder S. Shargill, Mark Dransfield, Dirk-Jan Slebos, Michael Perch

MARC

LEADER 00000caa a2200000 c 4500
001 1917165811
003 DE-627
005 20250716231610.0
007 cr uuu---uuuuu
008 250213s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.rmed.2024.107639  |2 doi 
035 |a (DE-627)1917165811 
035 |a (DE-599)KXP1917165811 
035 |a (OCoLC)1528018706 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Koster, David  |e VerfasserIn  |0 (DE-588)120949924X  |0 (DE-627)1697022669  |4 aut 
245 1 0 |a Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves  |c T. David Koster, Pallav L. Shah, Arschang Valipour, Gerard J. Criner, Felix J. F. Herth, Richard Sue, Douglas K. Hogarth, Ralitza T. Martin, Amit K. Mahajan, Raed Alalawi, Lisa Kopas, Avi Cohen, Douglas E. Wood, Jonathan Kurman, Narinder S. Shargill, Mark Dransfield, Dirk-Jan Slebos, Michael Perch 
264 1 |c June 2024 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.02.2025 
520 |a Bronchoscopic lung volume reduction treatment with Zephyr one-way valves is an effective guideline-based treatment option for patients with severe emphysema and hyperinflation. However, in some cases the treatment response is less than anticipated or there might be a loss of initial treatment effect. Reasons for the lack of response can include incorrect assessment of collateral ventilation, improper valve placement, or patient related factors. Loss of initial benefit can be due to granulation tissue formation and subsequent valve dysfunction, or there may be side effects such as excessive coughing or infectious problems. Careful follow-up after treatment with valves is important and evaluation with a CT scan and/or bronchoscopy is helpful if there is no improvement after treatment or loss of initial benefit. This paper aims to describe the most important causes and provide a strategy of how to approach and manage these patients. 
650 4 |a Bronchoscopic lung volume reduction 
650 4 |a Bronchoscopy 
650 4 |a COPD 
650 4 |a Endobronchial valves 
650 4 |a Granulation tissue 
650 4 |a Pneumothorax 
700 1 |a Shah, Pallav L.  |e VerfasserIn  |4 aut 
700 1 |a Valipour, Arschang  |e VerfasserIn  |4 aut 
700 1 |a Criner, Gerard J.  |e VerfasserIn  |4 aut 
700 1 |a Herth, Felix  |e VerfasserIn  |0 (DE-588)1016095236  |0 (DE-627)705477568  |0 (DE-576)351509925  |4 aut 
700 1 |a Sue, Richard  |e VerfasserIn  |4 aut 
700 1 |a Hogarth, Douglas K.  |e VerfasserIn  |4 aut 
700 1 |a Martin, Ralitza T.  |e VerfasserIn  |4 aut 
700 1 |a Mahajan, Amit K.  |e VerfasserIn  |4 aut 
700 1 |a Alalawi, Raed  |e VerfasserIn  |4 aut 
700 1 |a Kopas, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Cohen, Avi  |e VerfasserIn  |4 aut 
700 1 |a Wood, Douglas E.  |e VerfasserIn  |4 aut 
700 1 |a Kurman, Jonathan  |e VerfasserIn  |4 aut 
700 1 |a Shargill, Narinder S.  |e VerfasserIn  |4 aut 
700 1 |a Dransfield, Mark  |e VerfasserIn  |4 aut 
700 1 |a Slebos, Dirk-Jan  |e VerfasserIn  |4 aut 
700 1 |a Perch, Michael  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Respiratory medicine  |d Burlington, Mass. : Harcourt, 1999  |g 227 (2024), [Artikelnummer] 107639, Seite [1]-8  |h Online-Ressource  |w (DE-627)320420973  |w (DE-600)2002557-9  |w (DE-576)103746870  |x 1532-3064  |7 nnas  |a Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves 
773 1 8 |g volume:227  |g year:2024  |g month:06  |g elocationid:107639  |g extent:8  |a Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves 
856 4 0 |u https://doi.org/10.1016/j.rmed.2024.107639  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0954611124001136  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250213 
993 |a Article 
994 |a 2024 
998 |g 1016095236  |a Herth, Felix  |m 1016095236:Herth, Felix  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1016095236  |e 950000PH1016095236  |e 950900PH1016095236  |e 50000PH1016095236  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 8 
999 |a KXP-PPN1917165811  |e 4663880703 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Koster, David","given":"David","family":"Koster","role":"aut"},{"display":"Shah, Pallav L.","given":"Pallav L.","family":"Shah","role":"aut"},{"family":"Valipour","given":"Arschang","display":"Valipour, Arschang","role":"aut"},{"display":"Criner, Gerard J.","given":"Gerard J.","family":"Criner","role":"aut"},{"role":"aut","given":"Felix","display":"Herth, Felix","family":"Herth"},{"role":"aut","family":"Sue","given":"Richard","display":"Sue, Richard"},{"display":"Hogarth, Douglas K.","given":"Douglas K.","family":"Hogarth","role":"aut"},{"role":"aut","given":"Ralitza T.","display":"Martin, Ralitza T.","family":"Martin"},{"family":"Mahajan","display":"Mahajan, Amit K.","given":"Amit K.","role":"aut"},{"given":"Raed","display":"Alalawi, Raed","family":"Alalawi","role":"aut"},{"role":"aut","family":"Kopas","display":"Kopas, Lisa","given":"Lisa"},{"family":"Cohen","display":"Cohen, Avi","given":"Avi","role":"aut"},{"role":"aut","display":"Wood, Douglas E.","given":"Douglas E.","family":"Wood"},{"role":"aut","given":"Jonathan","display":"Kurman, Jonathan","family":"Kurman"},{"display":"Shargill, Narinder S.","given":"Narinder S.","family":"Shargill","role":"aut"},{"role":"aut","family":"Dransfield","display":"Dransfield, Mark","given":"Mark"},{"family":"Slebos","given":"Dirk-Jan","display":"Slebos, Dirk-Jan","role":"aut"},{"role":"aut","given":"Michael","display":"Perch, Michael","family":"Perch"}],"recId":"1917165811","origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"June 2024"}],"name":{"displayForm":["T. David Koster, Pallav L. Shah, Arschang Valipour, Gerard J. Criner, Felix J. F. Herth, Richard Sue, Douglas K. Hogarth, Ralitza T. Martin, Amit K. Mahajan, Raed Alalawi, Lisa Kopas, Avi Cohen, Douglas E. Wood, Jonathan Kurman, Narinder S. Shargill, Mark Dransfield, Dirk-Jan Slebos, Michael Perch"]},"language":["eng"],"title":[{"title_sort":"Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves","title":"Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves"}],"physDesc":[{"extent":"8 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1016/j.rmed.2024.107639"],"eki":["1917165811"]},"relHost":[{"part":{"year":"2024","extent":"8","volume":"227","text":"227 (2024), [Artikelnummer] 107639, Seite [1]-8"},"id":{"eki":["320420973"],"zdb":["2002557-9"],"issn":["1532-3064"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 21.02.20"],"origin":[{"dateIssuedKey":"1999","publisherPlace":"Burlington, Mass.","publisher":"Harcourt","dateIssuedDisp":"1999-"}],"title":[{"title":"Respiratory medicine","title_sort":"Respiratory medicine"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["83.1989 -"],"recId":"320420973","disp":"Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valvesRespiratory medicine","language":["eng"]}],"note":["Gesehen am 13.02.2025"]} 
SRT |a KOSTERDAVIOPTIMIZING2024